These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 2114791)

  • 41. Stability of milrinone in 0.45% sodium chloride, 0.9% sodium chloride, or 5% dextrose injections.
    Wilson TD; Forde MD; Crain AV; Dombrowski LJ; Joyce MA
    Am J Hosp Pharm; 1986 Sep; 43(9):2218-20. PubMed ID: 3766576
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stability of cefotaxime in two peritoneal dialysis solutions.
    Paap CM; Nahata MC
    Am J Hosp Pharm; 1990 Jan; 47(1):147-50. PubMed ID: 2301423
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Compatibility of calcium chloride and calcium gluconate with sodium phosphate in a mixed TPN solution.
    Henry RS; Jurgens RW; Sturgeon R; Athanikar N; Welco A; Van Leuven M
    Am J Hosp Pharm; 1980 May; 37(5):673-4. PubMed ID: 6770681
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [A study on factors influencing the stability of total nutrient admixture].
    Zhang LH
    Zhonghua Wai Ke Za Zhi; 1991 Jun; 29(6):353-6, 396. PubMed ID: 1935432
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Compatibility of cyclosporine with fat emulsion.
    Jacobson PA; Maksym CJ; Landvay A; Weiner N; Whitmore R
    Am J Hosp Pharm; 1993 Apr; 50(4):687-90. PubMed ID: 8470685
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cimetidine hydrochloride compatibility. I: Chemical aspects and room temperature stability in intravenous infusion fluids.
    Rosenberg HA; Dougherty JT; Mayron D; Baldinus JG
    Am J Hosp Pharm; 1980 Mar; 37(3):390-2. PubMed ID: 7369222
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of retrograde aminophylline administration on calcium and phosphate solubility in neonatal total parenteral nutrient solutions.
    Kirkpatrick AE; Holcombe BJ; Sawyer WT
    Am J Hosp Pharm; 1989 Dec; 46(12):2496-500. PubMed ID: 2513716
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Calcium and phosphate solubility in neonatal parenteral nutrient solutions containing Aminosyn PF.
    Fitzgerald KA; MacKay MW
    Am J Hosp Pharm; 1987 Jun; 44(6):1396-400. PubMed ID: 3113238
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stability and compatibility of minocycline hydrochloride and rifampin in intravenous solutions at various temperatures.
    Pearson SD; Trissel LA
    Am J Hosp Pharm; 1993 Apr; 50(4):698-702. PubMed ID: 8470688
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stability of dobutamine hydrochloride in peritoneal dialysis solutions.
    Gora ML; Seth S; Visconti JA; Shields B; Bay W
    Am J Hosp Pharm; 1991 Jun; 48(6):1234-7. PubMed ID: 1858802
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Stability of vancomycin hydrochloride in various concentrations of dextrose injection.
    Nahata MC; Miller MA; Durrell DE
    Am J Hosp Pharm; 1987 Apr; 44(4):802-4. PubMed ID: 3578315
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Compatibility and stability of ondansetron hydrochloride, dexamethasone, and lorazepam in injectable solutions.
    McGuire TR; Narducci WA; Fox JL
    Am J Hosp Pharm; 1993 Jul; 50(7):1410-4. PubMed ID: 8362872
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Compatibility and stability of ondansetron hydrochloride with morphine sulfate and with hydromorphone hydrochloride in 0.9% sodium chloride injection at 4, 22, and 32 degrees C.
    Trissel LA; Xu Q; Martinez JF; Fox JL
    Am J Hosp Pharm; 1994 Sep; 51(17):2138-42. PubMed ID: 7527184
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The mode of delivery of parenteral multivitamins influences nutrient handling in an animal model of total parenteral nutrition.
    Chessex P; Friel J; Harrison A; Rouleau T; Lavoie JC
    Clin Nutr; 2005 Apr; 24(2):281-7. PubMed ID: 15784490
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stability of vancomycin hydrochloride in 5% dextrose and 0.9% sodium chloride injections.
    Das Gupta V; Stewart KR; Nohria S
    Am J Hosp Pharm; 1986 Jul; 43(7):1729-31. PubMed ID: 3752110
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Compatibility and stability of labetalol hydrochloride in commonly used intravenous solutions.
    Yuen PH; Taddei CR; Wyka BE; Chaudry IA
    Am J Hosp Pharm; 1983 Jun; 40(6):1007-9. PubMed ID: 6869384
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Stability of Ranitidine Hydrochloride with Cefazolin Sodium, Cefbuperazone Sodium, Cefoxitin Sodium and Cephalothin Sodium during Simulated Y-Site Administration.
    Inagaki K; Miyamoto Y; Kurata N; Nakane S; Gill MA; Nishida M
    Int J Pharm Compd; 2000; 4(2):150-3. PubMed ID: 23985950
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Concentration uniformity of extemporaneously prepared ranitidine suspension.
    Karnes HT; Harris SR; Garnett WR; March C
    Am J Hosp Pharm; 1989 Feb; 46(2):304-7. PubMed ID: 2712050
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stability of foscarnet sodium in 0.9% sodium chloride injection.
    Woods K; Steinmann W; Bruns L; Neels JT
    Am J Hosp Pharm; 1994 Jan; 51(1):88-90. PubMed ID: 8135266
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stability of dobutamine hydrochloride in selected large-volume parenterals.
    Kirschenbaum HL; Aronoff W; Perentesis GP; Piltz GW; Goldberg RJ; Cutie AJ
    Am J Hosp Pharm; 1982 Nov; 39(11):1923-5. PubMed ID: 7148861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.